Biological Therapies in Cancer Treatment to Reach $66 Billion in 2019; Biosimilars Proving to be a Major Driving Factor
According to the new report from BCC Research, the global market for biologic cancer treatment totaled about $51.2 billion in 2014 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of 5.4% for the period 2014-2019. (PRWeb March 24, 2015) Read the full story at http://www.prweb.com/releases/2015/03/prweb12592291.htm
Cancer Research UK scientists have discovered a new line of defence used by cancer cells to evade cell death, according to research published in Nature Communications today (Monday).
Cancer Research UK scientists have found a drug combination that can trigger the self-destruct process in lung cancer cells – paving the way for new treatments, according to research that will be presented at the National Cancer Research Institute Cancer Conference in Liverpool next week.
Sums spent on conditions bear little relation to their costs to health services, as compared with cancer or heart disease, say researchers Research funding into stroke and dementia in the UK is still too low despite recent significant rises in state support, a study says. While the gap between budgets for these two conditions and cancer and coronary heart disease (CHD) has narrowed in terms of …
( D'Or Institute for Research and Education ) Pneumonia is the most frequent type of infection in cancer patients and it is associated with high mortality rates. Brazilian researchers analyzed the factors associated with severe pneumonia in hospitalized cancer patients and suggest that personalized treatment protocols can reduce mortality in this population. Their work indicates that the …
( American Association for Cancer Research ) The American Association for Cancer Research (AACR) is honoring Owen N. Witte, M.D., founding director of the Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research and distinguished professor of microbiology, immunology, and molecular genetics at the University of California, Los Angeles, with the 55th annual AACR G.H.A
Mercy Medical Center has received a $50,000 grant from Ovarian Cancer Research Fund (OCRF) to establish “Woman to Woman,” a patient support program that pairs new gynecologic cancer patients with trained and supervised survivor volunteers to provide mentoring and support.
( Arizona State University ) In new research, Carlo Maley, Ph.D., and his colleagues describe compulsive evolution and dramatic genetic diversity in cells belonging to one of the most treatment-resistant and lethal forms of blood cancer: acute myeloid leukemia (AML).
Diane Blackburn-Zambetti of the Mesothelioma Applied Research Foundation will speak at the BoRit Asbestos Superfund Citizen Advisory Group Meeting in Ambler, Pennsylvania (PRWeb March 31, 2015) Read the full story at http://www.prweb.com/releases/2015/04/prweb12618670.htm